Answers are grounded in this paper and cite their sources.
Analysis reveals low complication rates associated with cefazolin in outpatient settings, suggesting monitoring adjustments may be feasible.
In outpatient parenteral antimicrobial therapy, weekly lab monitoring is often standard practice, even for antimicrobials with low complication rates. We reviewed 420 patients treated with cefazolin: lab abnormalities associated with readmission or treatment changes occurred in 2% of patients. Reduced-frequency monitoring may be reasonable for patients treated with cefazolin outpatient.
No takes yet. Share an insight, caveat, or question.
Poux et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: